Perspectum

Perspectum is a precision health technology company that provides body imagery software using artificial intelligence (AI) to aid medical professionals in the diagnosis and monitoring of patients with chronic diseases like metabolic conditions and cancer. The company's flagship product, LiverMultiScan, is a non-invasive MRI scan that quantitatively assesses and monitors chronic liver disease by measuring fat, iron, and disease activity levels in the liver. This technology connects to existing MRI machines and generates reports without requiring manual interpretation by physicians, potentially eliminating the need for invasive liver biopsies. Several major hospitals in the US, including Cedars-Sinai, Massachusetts General Hospital, and Lahey Health, have adopted LiverMultiScan. The software is covered by Medicare and commercial insurance providers like Anthem and Blue Cross Blue Shield plans.

Perspectum was founded in 2012 and has offices in the UK, US, Portugal, and Singapore. As of January 2023, the company had raised approximately USD 120 million in funding. In March 2023, Perspectum secured an additional USD 55 million in a Series C funding round led by Oppenheimer Holdings, bringing its total funding to around USD 140 million. The company plans to utilize these funds to expand its product offerings for multiorgan inflammatory conditions and oncology, as well as scale its operations in the US.

Key customers and partnerships

In March 2023, Perspectum announced a collaboration with Nuance Communications, a Microsoft company, to deliver its integrated digital platform suite for metabolic disease care and management at scale.